Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
10mm shares traded in the first hour, close to their average this month. The NY open will have confidence if they keep it afloat here. Stronger than I thought, doing good so far, fingers crossed.
Swiss might be able to take us green, good buying action. Between .49 & .5.
Some pressure at .5, but the bids keep stacking up.
They keep us in this range, they’ll have done their jobs. Just in case they give us a flash crash like a few weeks back, I’ve got my bids in.
Holding up nicely in Switzerland. Thought I’d get a chance to add on a bigger dip, but no complaints. Range is .46.-5.
Interferon beta, I’m sure there are others too.
Yea, he's ordering 100's of millions of doses on something where we have data on no more than 100-150 patients at this point.
Do you guys actually think about what you're typing? Do you think about your investments beyond lambo?
I can't even read this nonsense, makes me want to sell.
Short memories in here. Remember 2 weeks ago, it was a Monday, the stock was going to a bazillion bc of a press conference... we fell over 20% the following day. History just repeating itself in here. More cheerleading than analyzing taking place.
Believing the POTUS is going to be discussing our drug when the data is still be recruited and analyzed is as unrealistic an expectation you can set... yet here we are.
Relatively flat in Switzerland. The key problem with Switzerland is there are a lot of shares owned for .01 (or less). Regardless of where the share price could be heading, a lot of those with shares that are 50x what they were a month ago will book profit. I woke up anticipating this to be down large, but I was happy to see it flat. However, some of those who have been dumping in Switzerland prob realized they’re killing confidence bc volume over there is super low as of now. It’s been averaging about 80mm shares a day this week, today it’s flat on volume of only 13mm.
You're going to want to watch the actual dollar amounts coming in. Once you see consistent $50mm in daily volume, you'll know some smart money is finding its way in. Over $100mm and more has found their way.
For now, it's idiots similar to us passing it around.
Alright, I have stuff do, good luck fellas, let's do this!
The Swiss have a large sell wall up at .6, which is about .66 in the USA. Hopefully they bust through it, but they might need our help when we open. Someone doesn't want this to go up, let's punish them.
Really? Bc I didn't see anybody dissect the data, which is why I did so last night. You can take my word or read through my posts.
And please, show me where it was analyzed before I posted the numbers.
Opened back up at the same price, now .594.
The Swiss need the Americans to carry this, that press release gives us the ammunition.
Let's go!
If anyone wants to compare the two papers, look at pages 3 & 5, the one circulating from last night quoted 6 patients (3 males and 3 females) on page 3. This one correctly identifies the numbers. Similar error on page 5.
The company just made that paper official, but without the same errors, it's a good thing and we can now confirm it is real.
It will not be. It will resume trading at 8:45am EDT in Switzerland and open as scheduled at 9:30am in the US.
As I noted yesterday, the paper was littered with grammatical errors. I was correct, the one on the SSRN server cleans these up. It was leaked before it was concluded.
Relief just validated the paper and updated the grammatical errors with a printed copy and notes it in their press release, this is the reason they requested a halt. Take a deep breath, a halt can be scary, this one is not. Anyone who read the print from last night now knows it is valid and from the company (except the cleaner version was just released).
This is good.
We’re consolidating at a higher level, this is a good thing. Just exercise some patience.
While it varies on the exchange rate daily, the Swiss Franc is roughly 1.1 to 1 in USD for simple math. Implied open is about .65 right now, but they usually climb out of their hole around 8-830 and start buying, I anticipate that happening this morning.
Currently .592. Someone just bought 1mm shares 5 minutes ago.
In following the patterns, this should rise steadily in Switzerland today between 8:30 and 9:30am EDT. I suspect it’ll be in the .63-.65 (Francs) range at the US open.
Sent me an IM telling me to shave my back; seems unhinged to me. I got a good chuckle, def someone I would take investing advice from.
This is incorrect. Why would they just wait for someone to enroll? What good does that do for the data committee? The patients need to receive the treatment before data can be looked at.
Patience, this is a process. In investing, wealth is passed from the impatient to the patient.
Last week Dr Javitt said they were doing an interim after 102 patients, at that point he said they had 86-87 enrolled. Assuming word of Aviptadil is spreading and they filled this week, with primary end point being alive and free of respiratory failure at 7 days (or 10, I forget, need to look it up), I assume we won’t see anything there until next week at the absolute earliest.
These last patients need to get to 7 or 10 days before their data will be looked at by the DSMC.
Who actually read the preprint? I honestly haven’t seen any discussion about it. There are two errors, one on page 3 and another on page 5. I’d love to know where it came from because I find it hard to believe they’d let this out mistaking 6 patients for 21. It’s shocking to me that in all the threads here and Yahoo not a single person mentioned this. Does anyone investing here do any due diligence, yet alone read 8 simple pages, I really don’t get it.
Diving into the data is impressive. We have patients with comorbidities, but we don’t know what they are. What we do know about these 21 patients is that they were the sickest of the sick. Probably a 20-30% survival rate. When you’re as ill as these people you don’t just get up and walk out of the hospital, the print makes that clear. Here is the data as of 21 days:
2 perished, one unrelated to COVID. 10 discharged, 8 are still on vents. If half of those on vents survive, we’re in the neighborhood of a 2/3 survival rate amongst the most ill, that’s def at the front of the pack for a treatment. I’m excited for the inhaler trial to start next month, and building on the excitement from their current trials, I would expect them to enroll fast. That’s really where this company can shine, if that works, prevents progression to severe COVID, then big pharma comes in and buys the drug for like $20B.
Please provide me a link to this. Unless NeuroRX bought the drug, Relief owns it. If they did buy it, this would’ve been disclosed.
Dr Javitt is the vice chair of the board and Ram has stated verbatim Relief owns the drug. The lawsuits that would happen in your scenario would destroy both of them.
Yes, that is the issue, he is extremely ill. Survival for these patients becomes much less likely. If the drug was available earlier, it could be very useful.
Hoping he gets it and recovers quickly!
The POTUS is pushing snake oil with no proven clinical trials for the financial benefit of his friends while people die. Let’s just call it what it is.
The Houston Fire Department is openly trying to save their captain and they’re asking for Aviptadil. Amazingly, I trust the HFD more than our Pres, it’s pretty sad.
It’s a CNN story if they get wind of it.
CNN, Bloomberg, etc... you want a story there? Houston Fire Department Captain is on a vent and ecmo. The department just asked Relief for their drug on their FB page. This is a CNN national exposure story if you want one. Get to work and get the story out.
https://www.google.com/amp/s/abc13.com/amp/hfd-firefighter-battling-covid-19-pandemic/6374632/
Thank you!
I’m not familiar with stair step, going to do some reading on it now.
ETA:
I don’t see any therapeutic company as of now receiving warp speed money, so that resolves my question for now.
Look, I know a lot of you are excited, but attention to detail is important. If Trump was so excited about Relief, why haven’t they received any WapSpeed money? It’s a legit question that should be answered with logic. I’ve got nothing, somebody think it through and provide some sound logic to that question, TIA.
Yes, but the implied open based on the US is down about 10-11%, sadly. We’ll see where it is at 3am EDT. The US carried this north last week, maybe the Swiss can lead the charge this one.
Tbh, if we consolidated at these levels for a few days, I’d be okay with that.
A question about a patent is a legitimate question. Should this drug be approved, any analyst is going analyze what type of profit and for how long to figure out their price targets and make buying/selling decisions.
With that, the most important thing right now is seeing positive data coming out, the patent issue and modeling earnings will be a good problem to have, but that’s not where this is right now... I’m hopeful we do get there though.
It doesn't go up everyday, I'm going to point that out to everyone. It's something that shouldn't have to be said, but I'm saying it anyways.
I've never posted here because I don't buy these little shtty pump and dump penny stocks. I invest when I see opportunities, and I saw one here with Relief and NeuroRX. The day too day is noise. Traders moving in and out, some people taking profits, etc. etc.. That's natural.
This isn't going to play out in a week. There will be big movements up and down, if you are going to get scared and panic sell, just get out now. This is a play that will take months to play out.
Personally, I don't believe a top 1% cited scientist joined the company to pump a share price for one week, he's in it for a treatment for Covid (Dr. Javitt). We have a pro handling the money (Ram), he isn't going to let anyone run him over, these small cap biotechs are his playground. If you believe they have a viable treatment, tune out the noise, walk away from the ticker, set an order for lower to buy a dip, and take a few deep breaths.
I believe the direction over the next few months will be up, but I also KNOW there will be turbulence getting there.
TCM55, FYI; 121mm shares traded on the Swiss Exchange, very bullish close too.
Lol, right up there with the Cavuto interview.
I’m obviously a bull, so don’t take any offense to this, but I see so many people on message boards that have “insider” word, it always makes me such a skeptic. There are only a handful of people at Houston Methodist that would know this, maybe 10 people in total, you know one of these 10 people?
This is how people lose their shares. They set their expectations to the moon and when they aren’t met, they capitulate and sell. If there is smart money wanting in, they want it lower, not higher. Just be cognizant of that.
If it goes lower, don’t be scared, last weeks move was gargantuan. As word spreads, more money will want in, don’t fold and don’t be scared.
Do you think he has shared everything he knows? Maybe he is basing his statements on information not yet publicly available, IMO.
You need to tweet it at Trump and add a light insult at Fauci For not finding it to get his attention. Buzzword like cure in the tweet too. Need an army of people tweeting it to him.
Tweeting it into air won’t do anything.
You said $4B, I told you you were 400% over. Bottom line, go find a broker to loan you some shares, that’ll end well lmao.
Tweet Dave Portnoy (El Prez)
One last point, small detail that you all hopefully already noticed or discussed:
https://www.businesswire.com/news/home/20200715005954/en/%C2%A0NeuroRx-Relief-Therapeutics-Announce-Data-Monitoring-Committee
Quote (pay attention to the underlined, we already know who is on this committee):
The study protocol enrolls patients with Critical COVID-19 and Respiratory Failure and randomly assigns them to intravenous RLF-100 or Placebo in the hopes of achieving remission from this most-serious stage of COVID-19. At the committee’s recommendation, the primary endpoint is changed to “alive and free of respiratory failure at 7-10 days.” This change in primary endpoint from mortality at 28 days is driven by the general decrease in mortality with advances in treatment for Critical COVID-19 and by initial observations in the clinical trial.